Showing results (231-240 of 370) with videos related to

Sort By:
Pageof 37
Environmental Science & Technology|June 27, 2025
Machine Learning and Large Language Models for Modeling Complex Toxicity Pathways and Predicting SteroidogenesisThomas R Lane, Patricia A Vignaux, Joshua S Harris, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 30, 2006
Three-dimensional quantitative structure-activity relationship analysis of human CYP51 inhibitorsSean Ekins, Dayna C Mankowski, Dennis J Hoover, et al.
Pharmaceutical Research|July 1, 2018
Naïve Bayesian Models for Vero Cell CytotoxicityAlexander L Perryman, Jimmy S Patel, Riccardo Russo, et al.
Chemical Research in Toxicology|February 16, 2010
Integrated in silico-in vitro strategy for addressing cytochrome P450 3A4 time-dependent inhibitionMichael Zientek, Chad Stoner, Robyn Ayscue, et al.
Pharmaceutical Research|April 23, 2005
In vitro and pharmacophore-based discovery of novel hPEPT1 inhibitorsSean Ekins, Jeffrey S Johnston, Praveen Bahadduri, et al.
Molecular Pharmacology|September 10, 2021
Remdesivir and EIDD-1931 Interact with Human Equilibrative Nucleoside Transporters 1 and 2: Implications for Reaching SARS-CoV-2 Viral Sanctuary SitesSiennah R Miller, Meghan E McGrath, Kimberley M Zorn, et al.
Journal of Chemical Information and Modeling|July 16, 2024
Near-Term Quantum Classification Algorithms Applied to Antimalarial Drug DiscoveryMatthew A Dorsey, Kelvin Dsouza, Dhruv Ranganath, et al.
Chemical Research in Toxicology|August 31, 2023
Human CYP2C19 Substrate and Inhibitor Characterization of Organophosphate PesticidesPatricia A Vignaux, Pratik Shriwas, Andre Revnew, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 13, 2021
Multiple Computational Approaches for Predicting Drug Interactions with Human Equilibrative Nucleoside Transporter 1Siennah R Miller, Thomas R Lane, Kimberley M Zorn, et al.
Pageof 37